Fact CheckerSign in

NCT06671067Not yet recruiting

Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction

Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing (ReDS™) Technology to Improve Cardiac Insufficiency During Ischemia-reperfusion and Clinical Outcomes in Myocardial Infarction

Source: ClinicalTrials.gov · Last updated 4 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To explore whether a ReDS-guided strategy for AMI patients with cardiac insufficiency following coronary flow reperfusion is superior to routine care for improving outcomes.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
2000 (estimated)
First submitted
29 Oct 2024
Start date
1 Nov 2024
Primary completion date
31 Dec 2026
Lead sponsor
Shanghai 10th People's Hospital
NCT number
NCT06671067

What you commit to

  • Study type: Interventional
  • Planned participants: 2000
  • From 1 Nov 2024 to the primary completion date, 31 Dec 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with chronic obstructive pulmonary disease or other lung diseases that might confound ReDS values
  • Patients with a left ventricular assist device or undergoing cardiac transplantation;
  • Patients with congenital heart malformations or intrathoracic mass that would affect right lung anatomy;
  • Patients with end-stage renal disease on hemodialysis;

Other

  • Patient's physical characteristics that prevented the use of the ReDS system (height of \<155 or \>190 cm; body mass index of \<22 or \>39 kg/m2)
  • Patients whose life expectancy less than 12 months due to noncardiac comorbidities
  • Patients who participate in another randomized studies.

Who the study is looking for

  • Patients were required to be aged ≥ 18 years and to be hospitalized for a primary diagnosis of AMI,
  • AMI patients accompanied by cardiac insufficiency following coronary revascularization, which is characterized by the symptoms and signs of fluid overload, regardless of left ventricular ejection fraction (LVEF), and have an N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration of ≥ 400 pg/L or a BNP concentration of ≥ 100 pg/L.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Huaihe Hospital of Henan University
Coordinator of this site? Confirm its status
KaifengChinaUnknown status
Kaifeng Central Hospital
Coordinator of this site? Confirm its status
KaifengChinaUnknown status
Shanghai Tenth People's Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine Shanghai
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
The First Affiliated Hospital of Zhengzhou University
Coordinator of this site? Confirm its status
ZhengzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.